EUVIMEDEUVIMED entdecken
Leserbrief

Dosing Time of Day Impacts the Safety of Antiarrhythmic Drugs in a Computational Model of Cardiac Electrophysiology

Ning Wei, Casey O Diekman iD

Journal of Biological Rhythms · 2025

DOI: 10.1177/07487304251326628 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Biological Rhythms, 2025. Verfasst von Ning Wei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, Purdue University, West Lafayette, Indiana. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Circadian Rhythm, Heart. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Division of Mathematical Sciences, Simons Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circadian clocks regulate many aspects of human physiology, including cardiovascular function and drug metabolism. Administering drugs at optimal times of the day may enhance effectiveness and reduce side effects. Certain cardiac antiarrhythmic drugs have been withdrawn from the market due to unexpected proarrhythmic effects such as fatal Torsade de Pointes (TdP) ventricular tachycardia. The Comprehensive in vitro Proarrhythmia Assay (CiPA) is a recent global initiative to create guidelines for the assessment of drug-induced arrhythmias that recommends a central role for computational modeling of ion channels and in silico evaluation of compounds for TdP risk. We simulated circadian regulation of cardiac excitability and explored how dosing time of day affects TdP risk for 11 drugs previously classified into risk categories by CiPA. The model predicts that a high-risk drug taken at the most optimal time of day may actually be safer than a low-risk drug taken at the least optimal time of day. Based on these proof-of-concept results, we advocate for the incorporation of circadian clock modeling into the CiPA paradigm for assessing drug-induced TdP risk. Since cardiotoxicity is the leading cause of drug discontinuation, modeling cardiac-related chronopharmacology has significant potential to improve therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Arrhythmia AgentsCircadian RhythmHeartHumansComputer SimulationTorsades de PointesArrhythmias, CardiacCircadian ClocksModels, Cardiovascular

Stichwörter der Autor:innen

Comprehensive in vitro Proarrhythmia Assay (CiPA)cardiac electrophysiologychronopharmacologycircadian rhythmscomputational modelingion channels

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Mathematics, Purdue University, West Lafayette, Indiana.
  • Department of Mathematical Sciences, New Jersey Institute of Technology, Newark, New Jersey.

ORCID-Profile: Casey O Diekman

Förderung

  • Division of Mathematical Sciences
  • Simons Foundation

Zitieren

APA

Wei, N., & Diekman, C. O. (2025). Dosing Time of Day Impacts the Safety of Antiarrhythmic Drugs in a Computational Model of Cardiac Electrophysiology. Journal of Biological Rhythms. https://doi.org/10.1177/07487304251326628

Vancouver

Wei N, Diekman CO. Dosing Time of Day Impacts the Safety of Antiarrhythmic Drugs in a Computational Model of Cardiac Electrophysiology. Journal of Biological Rhythms. 2025. doi:10.1177/07487304251326628

BibTeX
@article{Wei2025,
  author = {Wei, Ning and Diekman, Casey O},
  title = {Dosing Time of Day Impacts the Safety of Antiarrhythmic Drugs in a Computational Model of Cardiac Electrophysiology},
  journal = {Journal of Biological Rhythms},
  year = {2025},
  doi = {10.1177/07487304251326628}
}
Kostenlos starten →